Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Tiziana Life Sciences Ltd (TLSA)

The asset value for Tiziana Life Sciences (TLSA) tracked on this chart stands at 0.00. The business relies on a virtual operating model, outsourcing the verification of immune agents to third-party contractors to reduce costs. Tiziana Life Sciences focuses on non-invasive intranasal treatments for dementia and sclerosis. These projects are protected by humanitarian status, which precludes trade sanctions and ensures stable partnerships with Western scientists.
Tiziana Life Sciences Ltd - rincian analitis lan metrik utama (TLSA)

When constructing a long-term portfolio, fundamental screening requires assessing business value relative to operating profit. The EV/EBITDA multiple compares a company's total market value, accounting for debt and taxes, with its ability to generate cash flow. For Tiziana Life Sciences (TLSA), this metric reflects the capitalization of intellectual capital and patents for nasal immunotherapy. By analyzing fluctuations in the company's EV/EBITDA level, an investor determines the degree of asset overvaluation relative to the actual efficiency of its developments.